Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kawasumi Laboratories is a prominent Japanese medical device manufacturer specializing in disposable equipment for blood management and extracorporeal circulation. The company's core business segments include hemodialysis systems, blood collection and transfusion sets, and cardiovascular surgery products such as oxygenators and stent grafts. Founded in 1957, Kawasumi has built a global reputation for high-quality infusion therapy and dialysis components. In 2020, the company was acquired by Sumitomo Bakelite to strengthen its healthcare and medical materials division. Today, it operates as a key subsidiary within the Sumitomo Bakelite group, continuing to innovate in the fields of nephrology and vascular intervention.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kawasumi.